CPT code 85270: Factor XI assay, factor XI (PTA)2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Measures clotting factor XI activity, commonly to investigate a prolonged activated partial thromboplastin time or suspected factor XI deficiency.
Medicare pays $17.90 for 85270 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$17.90
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 85270 covers
This assay measures clotting factor XI, also called plasma thromboplastin antecedent (PTA), in a blood sample. It is generally performed on citrated plasma by a clinical laboratory using a clot-based activity method. Clinicians may order it when evaluating a prolonged activated partial thromboplastin time or suspected factor XI deficiency, including a bleeding history that raises concern for a coagulation factor deficiency. Hematology and coagulation laboratories typically perform and report the result.
Report this code for the factor XI measurement, rather than for a general coagulation screen or a different factor assay. The test is paid only under the Medicare Clinical Laboratory Fee Schedule. The 2026 national CLFS amount is $17.90, unchanged since 2020; the same amount applies across localities, without geographic or office-versus-facility adjustment. The physician fee schedule excludes this test by statute, so Medicare payment is through the CLFS.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 85270
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 85270. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 85270 with status X (excluded by statute), so the test itself is paid only from the CLFS.
85270 on the lab fee schedule since 2020
85270 · CLFS 2026 Q4 (current)
$17.90
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
85270 compared with similar tests
- 85280Factor XIIHageman factor activity$19.35
- Choose 85270 for factor XI measurement and 85280 for factor XII measurement; the assays address different causes of abnormal coagulation results.
- 85250Factor IX testPTC or Christmas factor$19.04
- 85250 is the factor IX assay. Use 85270 when the requested analyte is factor XI.
- 85240Factor VIIIOne-stage activity$17.90
- 85240 measures factor VIII activity. This code identifies testing for factor XI activity.
85270 billing questions
When is factor XI testing appropriate instead of a routine coagulation test?
Use this assay when the clinical question concerns factor XI activity, such as suspected factor XI deficiency. It measures a specific factor rather than screening overall clotting time.
What specimen is typically used?
The assay is generally performed on citrated plasma.
Should this code be reported with another factor assay?
Report a separate factor assay when the clinician orders and the laboratory performs measurement of another specific factor. Codes for factors VIII, IX, X, or XII identify those distinct analytes.
How does Medicare pay for this test?
Medicare pays it through the CLFS at one national amount for all localities, with no office-versus-facility difference. It is excluded from the physician fee schedule.
What should the record support?
Documentation should identify the factor XI assay performed and the clinical reason for testing, such as evaluation of a prolonged clotting screen or suspected factor XI deficiency.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 85270 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist